← All trials
NCT00399529
Phase 2Interventional
Includes controlled clinical studies conducted to evaluate the effectiveness of the drug for a particular indication or indications in participants with the disease or condition under study and to determine the common short-term side effects and risks.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 1, 2006
- Primary completion
- Feb 1, 2010
- Completion date
- Feb 1, 2010
- First posted
- —
- Last posted
- —
- Enrollment
- 22
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Johns Hopkins UniversityLead sponsor
- American Cancer Society, Inc.Collaborator
- Avon FoundationCollaborator
- Cancer Treatment Research FoundationCollaborator
- The Commonwealth FundCollaborator
- Johns Hopkins UniversityOverall official - principal investigator
- Department of DefenseCollaborator
- GenentechCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.